How everyone on Medicare could end up paying for the pricey new Alzheimer’s drug

  • by

The controversial new drug for Alzheimer’s disease, Aduhelm, is priced at $56,000 a year for treatment — but Alzheimer’s patients won’t be the only ones shouldering the cost.